Cost-effectiveness of pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: Qualitative synthesis of scientific evidence

2013 ◽  
Vol 6 (4) ◽  
pp. 168-177 ◽  
Author(s):  
Ferrán Catalá-López ◽  
Manuel Ridao ◽  
Gabriel Sanfélix-Gimeno ◽  
Salvador Peiró
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Cost Effectiveness ◽  
Children And Adolescents ◽  
Attention Deficit ◽  
Pharmacological Treatment ◽  
Scientific Evidence ◽  
Qualitative Synthesis ◽  
Hyperactivity Disorder

scholarly journals Pharmacological Treatment of Attention Deficit Hyperactivity Disorder in Children and Adolescents: Clinical Strategies

2012 ◽  
Vol 5 ◽  
pp. JCNSD.S6691 ◽  
Author(s):  
Anna C. Shier ◽  
Thomas Reichenbacher ◽  
Harinder S. Ghuman ◽  
Jaswinder K. Ghuman
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Children And Adolescents ◽  
Attention Deficit ◽  
Pharmacological Treatment ◽  
First Line ◽  
Pharmacological Agents ◽  
Ample Evidence ◽  
Hyperactivity Disorder ◽  
Impaired Quality

Attention deficit hyperactivity disorder (ADHD) is a common neurobehavioral disorder of childhood that can result in significant functional impairment, and if not adequately treated can lead to impaired quality of life. Pharmacotherapy is considered the first-line treatment for ADHD in children and adolescents. We review both recent literature and seminal studies regarding the pharmacological treatment of ADHD in children and adolescents. There is ample evidence for the efficacy and safety of both stimulants and non-stimulants in the treatment of ADHD. We review important aspects of evaluation and assessment and discuss first-line pharmacological treatments and as well as when to consider using alternative pharmacological agents. Treatment approaches to manage frequently seen comorbid disorders with ADHD are also covered.

Sign in / Sign up

Export Citation Format

Share Document